
Danaher Corporation DHR
€ 183.90
-0.08%
Quartalsbericht 2025-Q1
hinzugefügt 22.04.2025
Danaher Corporation DPO 2011-2026 | DHR
DPO Jährlich Danaher Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 66.4 | 67.1 | 77.2 | 88.1 | 66.3 | 69.7 | 71.2 | 67.7 | 71.8 | 76.3 | 72.3 | 70.9 | 63.8 | 65.6 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 88.1 | 63.8 | 71 |
DPO Vierteljährlich Danaher Corporation
| 2025-Q1 | 2024-Q4 | 2024-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 71.1 | - | - | - | - | 71.9 | 75.3 | - | 65.2 | 73.4 | 80.9 | - | 70.3 | 76.5 | 85.6 | - | 71.4 | 70.5 | 73.6 | - | 72.3 | 72.2 | 71.7 | - | 69.2 | 67.9 | 73 | - | 73.4 | 72.8 | 74.7 | - | 97 | 80.7 | 79.4 | - | 74.9 | 73 | 74.6 | - | 72.3 | 72.4 | 71.6 | - | 66 | 64.2 | 65.1 | - | 57.4 | 75.5 | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 97 | 57.4 | 73.1 |
DPO anderer Aktien in der Diagnostik & Forschung
| Name | DPO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
120 | - | -6.23 % | $ 30.6 M | ||
|
Anixa Biosciences
ANIX
|
1.29 K | $ 3.03 | -2.26 % | $ 98.3 K | ||
|
Trinity Biotech plc
TRIB
|
163 | $ 0.83 | -5.96 % | $ 61.9 M | ||
|
Akumin
AKU
|
21.3 | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
112 | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
56.3 | - | -13.05 % | $ 7.29 M | ||
|
Burning Rock Biotech Limited
BNR
|
125 | $ 34.5 | 2.16 % | $ 371 M | ||
|
Accelerate Diagnostics
AXDX
|
125 | - | -61.36 % | $ 2.46 M | ||
|
BioNano Genomics
BNGO
|
104 | $ 1.29 | -12.26 % | $ 1.64 M | ||
|
Castle Biosciences
CSTL
|
52 | $ 39.74 | 1.48 % | $ 1.1 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
45.8 | - | - | $ 562 M | ||
|
Chembio Diagnostics
CEMI
|
52.5 | - | 0.22 % | $ 16.8 M | ||
|
Co-Diagnostics
CODX
|
106 | - | - | $ 79.8 M | ||
|
Exact Sciences Corporation
EXAS
|
139 | $ 102.41 | 0.1 % | $ 19 B | ||
|
Fulgent Genetics
FLGT
|
34.9 | $ 26.19 | -0.19 % | $ 792 M | ||
|
DermTech
DMTK
|
47.4 | - | -11.32 % | $ 2.94 M | ||
|
Global Cord Blood Corporation
CO
|
17.7 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
61.4 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
780 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
43.5 | - | 0.12 % | $ 80.1 M | ||
|
Guardant Health
GH
|
83.6 | $ 113.17 | 2.43 % | $ 13.9 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
8.98 | - | - | $ 10.7 B | ||
|
DexCom
DXCM
|
70.4 | $ 73.31 | -0.93 % | $ 28.3 B | ||
|
CareDx, Inc
CDNA
|
44.2 | $ 20.55 | -1.23 % | $ 1.1 B | ||
|
DarioHealth Corp.
DRIO
|
43.9 | $ 10.2 | -0.97 % | $ 289 M | ||
|
Enzo Biochem
ENZ
|
52.3 | - | -8.98 % | $ 14.8 K | ||
|
Lantheus Holdings
LNTH
|
25.3 | $ 66.91 | 0.34 % | $ 4.63 B | ||
|
Heska Corporation
HSKA
|
39.7 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
112 | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
56.3 | $ 144.81 | -3.26 % | $ 23 B | ||
|
NeoGenomics
NEO
|
20.7 | $ 11.99 | -3.35 % | $ 1.52 B | ||
|
QIAGEN N.V.
QGEN
|
50 | - | - | $ 10.6 B | ||
|
IQVIA Holdings
IQV
|
126 | $ 230.33 | -2.19 % | $ 41.8 B | ||
|
Charles River Laboratories International
CRL
|
24.5 | $ 210.51 | -0.59 % | $ 10.8 B | ||
|
Personalis
PSNL
|
67.3 | $ 9.33 | -6.42 % | $ 553 M | ||
|
Medpace Holdings
MEDP
|
13.3 | $ 582.66 | -1.76 % | $ 18 B | ||
|
Quest Diagnostics Incorporated
DGX
|
18.3 | $ 186.45 | 2.27 % | $ 20.7 B | ||
|
Motus GI Holdings
MOTS
|
1.72 | - | -34.28 % | $ 263 K | ||
|
Precipio
PRPO
|
53 | $ 24.07 | -0.78 % | $ 31.2 M | ||
|
Laboratory Corporation of America Holdings
LH
|
33.1 | $ 271.34 | 0.56 % | $ 22.8 B | ||
|
Mettler-Toledo International
MTD
|
53.4 | $ 1 370.47 | -1.61 % | $ 29.1 B | ||
|
ICON Public Limited Company
ICLR
|
6.52 | $ 181.44 | -2.39 % | $ 15 B | ||
|
IDEXX Laboratories
IDXX
|
27 | $ 672.84 | -0.57 % | $ 55.5 B | ||
|
Agilent Technologies
A
|
50.1 | $ 133.33 | 0.07 % | $ 40.5 B |